Scott L Carter Selected Research

Scott L Carter Research Topics

Disease

37	Neoplasms (Cancer) 10/2021 - 04/2005
7	Neoplasm Metastasis (Metastasis) 11/2021 - 11/2015
7	Breast Neoplasms (Breast Cancer) 01/2020 - 04/2005
6	Brain Neoplasms (Brain Tumor) 01/2022 - 11/2015
5	Melanoma (Melanoma, Malignant) 01/2022 - 05/2012
5	Carcinogenesis 10/2015 - 01/2007
3	Meningeal Carcinomatosis 10/2021 - 01/2020
3	Lung Neoplasms (Lung Cancer) 01/2020 - 05/2015
3	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 05/2012
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2013
2	Meningioma (Meningiomas) 11/2018 - 01/2017
2	Anaplastic Thyroid Carcinoma 05/2017 - 10/2014
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Rectal Neoplasms (Rectal Cancer) 01/2019
1	Muscular Dystrophies (Muscular Dystrophy) 11/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2017
1	Uveal melanoma 01/2017
1	Leiomyosarcoma 01/2017
1	Teratoma (Teratoid Tumor) 11/2016
1	Carcinoma (Carcinomatosis) 11/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2016
1	sporadic Papillary renal cell carcinoma 01/2016
1	Adenocarcinoma of Lung 08/2015
1	Squamous Cell Carcinoma of Head and Neck 05/2015
1	Hemangioblastoma 12/2014
1	Osteosarcoma (Osteogenic Sarcoma) 12/2014
1	Ewing Sarcoma (Sarcoma, Ewing) 11/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2014
1	Adenocarcinoma 02/2014
1	Multiple Myeloma 01/2014
1	Starvation 05/2013

Drug/Important Bio-Agent (IBA)

11	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 08/2011
4	Proteins (Proteins, Gene)FDA Link 11/2018 - 02/2011
3	Immune Checkpoint InhibitorsIBA 01/2022 - 08/2015
3	pembrolizumabIBA 08/2020 - 01/2017
3	TOR Serine-Threonine KinasesIBA 11/2019 - 10/2014
3	RNA (Ribonucleic Acid)IBA 12/2014 - 01/2013
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021 - 01/2017
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 11/2019 - 01/2019
2	Phosphotransferases (Kinase)IBA 11/2019 - 01/2014
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2017 - 01/2014
2	AndrogensIBA 01/2017 - 05/2012
2	Messenger RNA (mRNA)IBA 01/2016 - 09/2013
2	Amino Acids FDA Link 08/2015 - 05/2013
2	Transcription Factors (Transcription Factor)IBA 11/2014 - 05/2012
2	ParaffinIBA 06/2014 - 01/2014
2	Formaldehyde (Formol)FDA Link 06/2014 - 01/2014
2	dabrafenibIBA 01/2014 - 01/2014
1	NivolumabIBA 10/2021
1	IpilimumabIBA 10/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	palbociclibIBA 01/2021
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2020
1	Proline (L-Proline)FDA Link 11/2019
1	salicylhydroxamic acid (SHAM)IBA 11/2019
1	ipatasertibIBA 11/2019
1	GDC-0084IBA 01/2019
1	DystrophinIBA 11/2018
1	Cisplatin (Platino)FDA LinkGeneric 12/2017
1	Biomarkers (Surrogate Marker)IBA 12/2017
1	abirateroneIBA 01/2017
1	UbiquitinIBA 01/2017
1	enzalutamideIBA 01/2017
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 01/2017
1	Fumarate Hydratase (Fumarase)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Estrogen ReceptorsIBA 01/2016
1	Cytokine Receptors (Cytokine Receptor)IBA 08/2015
1	Complement System Proteins (Complement)IBA 05/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2015
1	Tyrosine Kinase InhibitorsIBA 05/2015
1	ErbB Receptors (EGF Receptor)IBA 05/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2014
1	Small Interfering RNA (siRNA)IBA 12/2014
1	Everolimus FDA Link 10/2014
1	Nonsense Codon (Nonsense Mutation)IBA 10/2014
1	HLA-B Antigens (HLA-B)IBA 02/2014
1	NucleotidesIBA 02/2014
1	SmokeIBA 01/2014
1	raf KinasesIBA 01/2014
1	VemurafenibIBA 01/2014
1	trametinibIBA 01/2014
1	Mitogen-Activated Protein KinasesIBA 01/2014
1	Cytidine DeaminaseIBA 09/2013
1	UracilIBA 09/2013
1	Retroelements (Retrotransposon)IBA 09/2013
1	CytosineIBA 09/2013
1	CytidineIBA 09/2013
1	Mechanistic Target of Rapamycin Complex 1IBA 05/2013
1	Sirolimus (Rapamycin)FDA Link 05/2013
1	GTP Phosphohydrolases (GTPases)IBA 05/2013
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 05/2013
1	CateninsIBA 08/2012

Therapy/Procedure

18	Therapeutics 10/2021 - 06/2012
4	Immunotherapy 11/2021 - 01/2017
3	Drug Therapy (Chemotherapy) 12/2017 - 01/2016
1	Neoadjuvant Therapy 01/2019
1	Precision Medicine 01/2018
1	Castration 01/2017